المؤلفون: Noordhof, A.L., Damhuis, R.A.M., Hendriks, L.E.L., de Langen, A.J., Timens, W., Venmans, B.J.W., van Geffen, W.H.

المصدر: Noordhof , A L , Damhuis , R A M , Hendriks , L E L , de Langen , A J , Timens , W , Venmans , B J W & van Geffen , W H 2021 , ' Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy ' , Lung Cancer , vol. 155 , pp. 163-169 . https://doi.org/10.1016/j.lungcan.2021.04.001

مصطلحات موضوعية: Non-small cell lung cancer, Kirsten rat sarcoma, Mono-immunotherapy, PREDICTIVE-VALUE, CANCER, EFFICACY, INHIBITORS, DOCETAXEL, SURVIVAL, THERAPY

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/362f0094-c77c-498d-99dd-9e6879c64335
https://doi.org/10.1016/j.lungcan.2021.04.001

المؤلفون: Yazdi, M.T., Egberts, J., Schinkelshoek, M.S., Wolterbeek, R., Nabers, J., Venmans, B.J.W., Tournoy, K.G., Annema, J.T.

المصدر: Lung Cancer

مصطلحات موضوعية: Endosonography, NSCLC, Staging, EUS-FNA, EBUS-TBNA

Relation: lumc-id: 4337581; https://hdl.handle.net/1887/107889

الاتاحة: https://hdl.handle.net/1887/107889
https://doi.org/10.1016/j.lungcan.2015.09.020

المؤلفون: van Boxem, A.J.M, Westerga, J, Venmans, B.J.W, Postmus, P.E, Sutedja, G

المصدر: Lung Cancer ; volume 31, issue 1, page 31-36 ; ISSN 0169-5002

الاتاحة: http://dx.doi.org/10.1016/s0169-5002(00)00154-9
https://api.elsevier.com/content/article/PII:S0169500200001549?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0169500200001549?httpAccept=text/plain

المؤلفون: Venmans, B.J.W, van Kralingen, K.W, Chandi, D.D, de Vries, P.M.J.M, ter Wee, P.M, Postmus, P.E

المصدر: The Netherlands Journal of Medicine; May 1999, Vol. 54 Issue: 5 p207-212, 6p